期刊文献+

类风湿关节炎病人外周血T细胞亚群的表达及意义 被引量:2

STUDY ON T CELL SUBGROUP IN PERIPHERAL BLOOD OF PATIENTS WITH RHEUMATOID ARTHRITIS
下载PDF
导出
摘要 目的:探讨类风湿关节炎(rheumatoid arthritis,RA)病人外周血T细胞亚群的变化与RA发病机制及疾病发生发展的的关系。方法:检测50例RA病人和30例正常人进行外周血T细胞亚群的细胞数(流式细胞术)、类风湿因子及CRP(免疫沉淀法)、ESR(魏氏法),同时记录临床观察项目。结果:(1)活动期RA病人与健康对照组比较,外周血CD3+T淋巴细胞、CD4+T淋巴细胞无明显变化,差异无统计学意义(P>0.05);CD8+T淋巴细胞数明显减少,CD4+/CD8+比值增加,差异有统计学意义(P<0.05)。(2)活动期RA病人外周血CD8+T淋巴细胞的降低、CD4+/CD8+比值的升高,与缓解期RA病人比较差异具有统计学意义(P<0.05)。(3)缓解期RA病人与健康对照组比较,外周血T细胞亚群变化无统计学意义(P>0.05)。(4)缓解期与活动期RA病人比较,各临床参数均有明显改善。结论:异常细胞免疫状态参与了RA的发病过程,且与疾病的发生发展有关,CD4+/CD8+比值在RA的诊治中具有重要临床意义。 Objective:To analyze the relationship between variation of T cell subgroup in peripheral blood ( PB ) and pathogenesis and development of rheumatoid arthritis (RA). Methods: Sera from 50 patients with RA and 30 controls, T cell subgroup in PB was detected by flow cytometry. RF and CRP were detected by immuno - precipitation. ESR was examined by Westergren method, and recording the clinical observation items. Results: (1)There was no statistical difference between RA in active stage and controls about CD3+ and CD4+ ( P 〉 0. 05 ). CD8+ increased in RA which had difference with CD8 + T cell in PB reduced obviously and CD4 +/ controls(P 〈0. 05). (2)CD8 + T cell in PB reduced and CD4 +/CD8 + increased of RA in active stage which had difference with RA in remission stage (P 〈0. 05). (3)There was no statistical difference between RA in remission stage and controls about variation of T cell subgroup in PB (P 〉 0. 05). (4)The clinical parameter of RA in remission stage had more obvious improvement than RA in active stage. Conclusion:Abnormal cell immune plays a role in RA's pathogenesis and development. CD4+/CD8+ rate have important clinical significance for RA's diagnosis and treatment.
出处 《内蒙古医学院学报》 2008年第1期1-5,共5页 Acta Academiae Medicinae Neimongol
基金 内蒙古自治区自然科学基金(200711020952)
关键词 类风湿关节炎 T细胞亚群 流式细胞术 rheumatoid arthritis T cell subgroup flow cytometry
  • 相关文献

参考文献4

二级参考文献18

  • 1[1]Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med, 2000, 343: 1520~1528
  • 2[2]Suarez-Almazor ME, Belseck E, Shea B, et al. Methotrexate for treating rheumatoid arthritis (Cochrane Review). In: The Cochrane Library. Issue 4, 2001, Oxford: Update Software
  • 3[3]Smolen JS, Kalden JR, Scott DL, et al. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. Lancet, 1999, 353:259~266
  • 4[4]Dougados M, Combe B, Cantagrel A, et al. Combination therapy in early rheumatoid arthritis: a randomized, controlled,double blind 52 week clinical trial of sulfasalazine and methotrexate compared with the single components. Ann Rheum Dis, 1999, 58:220~225
  • 5[5]Hickling P, Jacoby RK, Kirwan JR, et al. Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Br J Rheumatol, 1998, 37:930~936
  • 6[6]Lipsky PE, van der Heijde DM, St. Clair EW, et al. For the Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study group. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med, 2000,343:1594~1602
  • 7[7]Highlignts of the Annual European Congress of Rheumatologh European League Against Rheumatism (EULAR 2003 )--aCanadian Thought-Leader Perspective. Medscape Rheumatology, posted 07/30/2003
  • 8[8]Report of the Asian Pacific League Against Rheumatism (APLAR)2002 Meeting. Medscape Rheumatology, posted 03/13/2003
  • 9[9]Medscape Conference Coverage, based on selected sessions at the American College of Rheumatology 67th Annual Scientific Meeting October 23~28, 2003, Orlando, Florida
  • 10Pich A, Chiusa L,Formiconi A,et al. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder [J]. Cancer, 2002, 95 (4):784-790.

共引文献15

同被引文献14

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部